Ponatinib coronary microangiopathy: novel bedside diagnostic approach and management with N-acetylcysteine.

Wu, Melinda D; Hodovan, James; Kumar, Kris; Moulton, Bart; Olson, Sven; Gilbert, Aubre; Wood, Matthew D; Lindner, Jonathan R

Wu, Melinda D; Hodovan, James; Kumar, Kris; Moulton, Bart; Olson, Sven; Gilbert, Aubre; Wood, Matthew D; Lindner, Jonathan R.

Afiliação

Wu MD; Division of Pediatric Hematology and Oncology, Doernbecher Children's Hospital, Portland, OR; and.
Hodovan J; Division of Pulmonary and Critical Care, Knight Cardiovascular Institute.
Kumar K; Division of Pulmonary and Critical Care, Knight Cardiovascular Institute.
Moulton B; Division of Hematology and Oncology, and.
Olson S; Division of Hematology and Oncology, and.
Gilbert A; Department of Pathology, Oregon Health & Science University, Portland, Oregon.
Wood MD; Department of Pathology, Oregon Health & Science University, Portland, Oregon.
Lindner JR; Division of Pulmonary and Critical Care, Knight Cardiovascular Institute.

Blood Adv ; 4(17): 4083-4085, 2020 09 08.

Article em En | MEDLINE | ID: mdl-32870969

Assuntos

Piridazinas; Doenças Vasculares; Acetilcisteína/uso terapêutico; Humanos; Imidazóis/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridazinas / Doenças Vasculares Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google